Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for AMINO ACIDS

    Client Email Product

    AMINO ACIDS

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    GLOBAL SALES INFORMATION

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    18
    US DMFs Filed

    US DMFs Filed

    18
    CEP/COS Certifications

    CEP/COS Certifications

    1
    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    0

    API REF. PRICE (USD / KG)

    0

    API Market Place

    0

    INTERMEDIATES
    1
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    165
    Europe

    Europe

    42
    Canada

    Canada

    0

    Australia

    Australia

    2
    South Africa

    South Africa

    107
    Uploaded Dossiers

    Uploaded Dossiers

    1
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS

    0

    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    10
    REF STANDARD

    EDQM

    1

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    left grey arrow
    right gray arrow
    • INJECTABLE;INJECTION - 10% (10GM/100ML)
    • INJECTABLE;INJECTION - 6% (6GM/100ML)
    Full View ScreenFull Screen View
    Enforcement Report - Week of September 6, 2023
    Enforcement Report - Week of September 6, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-6-2023-36272.pdf

    FDA
    06 Sep 2023
    Share Share
    Enforcement Report - Week of May 31, 2023
    Enforcement Report - Week of May 31, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-31-2023-56013.pdf

    FDA
    31 May 2023
    Share Share
    Enforcement Report - Week of July 27, 2022
    Enforcement Report - Week of July 27, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-27-2022-1659339221.pdf

    FDA
    27 Jul 2022
    Share Share
    Enforcement Report - Week Of June 01, 2022
    Enforcement Report - Week Of June 01, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-01-2022-1654158193.pdf

    FDA
    01 Jun 2022
    Share Share
     Baxter Announces USFDA Approval of Clinimix and Clinimix E
     Baxter Announces USFDA Approval of Clinimix and Clinimix E

    https://www.businesswire.com/news/home/20200923005309/en

    BUSINESSWIRE
    23 Sep 2020
    Share Share
    Biocon gets US FDA nod to launch insulin glargine
    Biocon gets US FDA nod to launch insulin glargine

    https://economictimes.indiatimes.com/industry/healthcare/biotech/biocon-gets-us-fda-nod-to-launch-insulin-glargine/articleshow/76333456.cms

    ECONOMICTIMES
    11 Jun 2020
    Share Share
    Enforcement Report - Week of October 30, 2019
    Enforcement Report - Week of October 30, 2019

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-30-2019-1572405657.pdf

    FDA
    30 Oct 2019
    Share Share
    US FDA Enforcement Report- 8/June/2016
    US FDA Enforcement Report- 8/June/2016

    https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-8june2016-1465388450.pdf

    FDA
    08 Jun 2016
    Share Share
    Amino acids as excipients for tackling poor aqueous solubility of valsartan
    Amino acids as excipients for tackling poor aqueous solubility of valsartan

    http://www.pharma-excipients.ch/2016/04/13/amino-acids-as-co-amorphous-excipients-for-tackling-the-poor-aqueous-solubility-of-valsartan/

    PHARMA-EXCIPIENTS
    12 Apr 2016
    Share Share
    Baxter Healthcare Corp., Ongoing Class II recall of Clinimix E 4.25/10 sulfite-free (4.25% Amino Acid with Electrolytes in 10% Dextrose with Calcium) Injections, in CLARITY Dual Chamber Container, Baxter Healthcare Corporation, Deerfield, IL NDC 0338-1115-04 because of Lack of Assurance of Sterility; leaks were observed from the bag seam and port seal
    Baxter Healthcare Corp., Ongoing Class II recall of Clinimix E 4.25/10 sulfite-free (4.25% Amino Acid with Electrolytes in 10% Dextrose with Calcium) Injections, in CLARITY Dual Chamber Container, Baxter Healthcare Corporation, Deerfield, IL NDC 0338-1115-04 because of Lack of Assurance of Sterility; leaks were observed from the bag seam and port seal

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0301-2015&w=12242014&lang=eng

    24 Dec 2014
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search